NanoEntek, Inc. (KOSDAQ:039860)
3,870.00
-180.00 (-4.44%)
At close: Nov 17, 2026
NanoEntek Revenue
NanoEntek had revenue of 12.51B KRW in the quarter ending June 30, 2026, with 39.43% growth. This brings the company's total for the last twelve months to 44.19B, up 29.61% year-over-year. In the year 2025, NanoEntek had annual revenue of 38.13B with 25.16% growth. That makes NanoEntek the 30,762nd largest company in the world by revenue and 1,938th in South Korea.
Revenue (ttm)
44.19B
Revenue Growth
+29.61%
P/S Ratio
3.31
Revenue / Employee
313.44M
Employees
141
Market Cap
146.45B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full NanoEntek breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.13B | 7.67B | 25.16% |
| Dec 31, 2024 | 30.46B | 3.63B | 13.52% |
| Dec 31, 2023 | 26.84B | -8.36B | -23.76% |
| Dec 31, 2022 | 35.20B | -583.53M | -1.63% |
| Dec 31, 2021 | 35.78B | 6.34B | 21.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dongkuk Industries | 658.12B |
| Aurora World | 359.90B |
| Oriental Precision & Engineering | 224.09B |
| Daihan Pharmaceutical | 216.55B |
| GC MediAI | 205.08B |
| Kyung Dong Pharmaceutical | 201.12B |
| MegaStudy | 122.99B |
| Ycchem | 98.32B |